1. Home
  2. INVO

as 07-26-2024 4:00pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
-
.
-
-
%

Stocks

Health Care

Medical/Dental Instruments

Nasdaq

INVO Bioscience Inc operates a healthcare services fertility company. Assisted Reproductive Technology (ART) marketplace by making fertility care more accessible and inclusive to people. Its commercial strategy is focused on operating fertility-focused clinics, which includes the opening of dedicated INVO Centers offering the INVOcell and IVC procedure (with three centers in North America now operational) and the acquisition of US-based, profitable in vitro fertilization (IVF) clinics. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors.

Founded: 2007 Country:
United States
United States
Employees: N/A City: SARASOTA
Market Cap: 3.4M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 40.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.55 EPS Growth: N/A
52 Week Low/High: $0.50 - $7.20 Next Earning Date: 08-12-2024
Revenue: $4,248,836 Revenue Growth: 321.67%
Revenue Growth (this year): 185.11% Revenue Growth (next year): 148.37%

INVO Daily Stock ML Predictions

Share on Social Networks: